[1]
R Mohamad Javier, “Risk Factors of Patients with Gangrene Pedis with Type 2 Diabetes Mellitus Followed by Anti-Diabetic and Insulin Drug Therapy”, J Popl Ther Clin Pharmacol, vol. 30, no. 13, pp. 108–117, Jun. 2023, doi: 10.47750/jptcp.2023.30.13.010.